The pharmacokinetic challenge of polymyxin B in critically ill patients with morbid obesity

J Glob Antimicrob Resist. 2021 Dec:27:172-174. doi: 10.1016/j.jgar.2021.09.004. Epub 2021 Sep 22.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Critical Illness
  • Humans
  • Obesity, Morbid* / drug therapy
  • Polymyxin B*

Substances

  • Anti-Bacterial Agents
  • Polymyxin B